AJP - Lung Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 289: L599-L605, 2005. First published June 17, 2005; doi:10.1152/ajplung.00061.2005
1040-0605/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/4/L599    most recent
00061.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, J. X.
Right arrow Articles by Janmey, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, J. X.
Right arrow Articles by Janmey, P. A.

Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum

Jay X. Tang,1,2 Qi Wen,1 Andrew Bennett,2 Brian Kim,2 Catherine A. Sheils,2,3 Robert Bucki,4 and Paul A. Janmey2,4

1Department of Physics, Brown University, Providence, Rhode Island; 2Hematology Division, Brigham and Women's Hospital, Boston; 3Pulmonary Division, Children's Hospital, Boston, Massachusetts; and 4Department of Physiology, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania

Submitted 3 February 2005 ; accepted in final form 11 June 2005

Bundles of F-actin and DNA present in the sputum of cystic fibrosis (CF) patients but absent from normal airway fluid contribute to the altered viscoelastic properties of sputum that inhibit clearance of infected airway fluid and exacerbate the pathology of CF. Previous strategies to remove these filamentous aggregates have focused on DNase to enzymatically depolymerize DNA to constituent monomers and gelsolin to sever F-actin to small fragments. The high densities of negative surface charge on DNA and F-actin suggest that the bundles of these filaments, which alone exhibit a strong electrostatic repulsion, may be stabilized by multivalent cations such as histones, antimicrobial peptides, and other positively charged molecules prevalent in airway fluid. This study reports that bundles of DNA or F-actin formed after addition of histone H1 or lysozyme are efficiently dissolved by soluble multivalent anions such as polymeric aspartate or glutamate. Addition of poly-aspartate or poly-glutamate also disperses DNA and actin-containing bundles in CF sputum and lowers the elastic moduli of these samples to levels comparable to those obtained after treatment with DNase I or gelsolin. Addition of poly-aspartic acid also increased DNase activity when added to samples containing DNA bundles formed with histone H1. When added to CF sputum, poly-aspartic acid significantly reduced the growth of bacteria, suggesting activation of endogenous antibacterial factors. These findings suggest that soluble multivalent anions have potential alone or in combination with other mucolytic agents to selectively dissociate the large bundles of charged biopolymers that form in CF sputum.

multivalent anions; polyelectrolyte; antimicrobial; LL37; cathelicidin



Address for reprint requests and other correspondence: R. Bucki, Dept. of Physiology, Inst. for Medicine and Engineering, Univ. of Pennsylvania, 1010 Vagelos Labs., 3340 Smith Walk, Philadelphia, PA 19104 (e-mail: buckirob{at}mail.med.upenn.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. J. Broughton-Head, J. Shur, M. P. Carroll, J. R. Smith, and J. K. Shute
Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1240 - L1249.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. Bucki, A. G. Sostarecz, F. J. Byfield, P. B. Savage, and P. A. Janmey
Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum
J. Antimicrob. Chemother., September 1, 2007; 60(3): 535 - 545.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. KATER, M. O. HENKE, and B. K. RUBIN
The Role of DNA and Actin Polymers on the Polymer Structure and Rheology of Cystic Fibrosis Sputum and Depolymerization by Gelsolin or Thymosin Beta 4
Ann. N.Y. Acad. Sci., September 1, 2007; 1112(1): 140 - 153.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. Bucki, F. J. Byfield, and P. A. Janmey
Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum
Eur. Respir. J., April 1, 2007; 29(4): 624 - 632.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.